CAR-T cell therapy makes strides in clinic *free*

(American Association for the Advancement of Science) In a phase 1 clinical study of 32 participants with advanced B cell non-Hodgkin lymphoma, immunotherapy with defined subsets of T cells, rather than whole T cell populations, showed strong antitumor activity.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news